Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood CellsKhadijah A. Mohammad, Moustafa E. El‐Araby, Asala H. Naghi et al.|Pharmaceuticals|2025Cited by 1
Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation PotentialAbdelsattar M. Omar, Martin K. Safo, Tarek A. Ahmed et al.|ChemMedChem|2025Cited by 1
Direct hemoglobin S polymerization inhibitor MCP435 completely halts ongoing disease pathophysiology in transgenic sickle cell disease miceAndrew N. Fleischman, Osheiza Abdulmalik, David R. Light et al.|Blood|2025Cited by 1
ILX-002 A Direct HbS Polymerization Inhibitor for the Treatment of Sickle Cell DiseaseOsheiza Abdulmalik, Martin K. Safo, David R. Light et al.|Journal of sickle cell disease.|2024Cited by 0
A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease - <i>In Vivo</i> Efficacy of Ilx-002 in Humanized MiceOsheiza Abdulmalik, Andrew N. Fleischman, Kandace Gollomp et al.|Blood|2024Cited by 0